Cargando…
Therapeutic implications of Epstein–Barr virus infection for the treatment of nasopharyngeal carcinoma
Nasopharyngeal carcinoma (NPC) is highly endemic in certain regions including the People’s Republic of China and Southeast Asia. Its etiology is unique and multifactorial, involving genetic background, epigenetic, and environment factors, including Epstein–Barr virus (EBV) infection. The presence of...
Autores principales: | Hutajulu, Susanna Hilda, Kurnianda, Johan, Tan, I Bing, Middeldorp, Jaap M |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4161530/ https://www.ncbi.nlm.nih.gov/pubmed/25228810 http://dx.doi.org/10.2147/TCRM.S47434 |
Ejemplares similares
-
Conserved mutation of Epstein-Barr virus-encoded BamHI-A Rightward Frame-1 (BARF1) gene in Indonesian nasopharyngeal carcinoma
por: Hutajulu, Susanna H, et al.
Publicado: (2010) -
Seroprevalence of IgA anti Epstein-Barr virus is high among family members of nasopharyngeal cancer patients and individuals presenting with chronic complaints in head and neck area
por: Hutajulu, Susanna Hilda, et al.
Publicado: (2017) -
Epstein-Barr virus and nasopharyngeal carcinoma
por: Young, Lawrence S., et al.
Publicado: (2014) -
Targeting Epstein-Barr Virus in Nasopharyngeal Carcinoma
por: Hau, Pok Man, et al.
Publicado: (2020) -
The role of Epstein–Barr virus in nasopharyngeal carcinoma
por: Su, Zhi Yi, et al.
Publicado: (2023)